Biernat Lukasz MD Concord, NH - 03301

Biernat Lukasz MD is categorized under Internal Medicine Practitioners in Concord, NH and active since 2010.

Biernat Lukasz MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Lukasz Biernat at the company’s single location by writing to 60 Commercial St # 401, Concord, New Hampshire NH 03301 or by phoning (603) 228-7555. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Biernat Lukasz MD
Contact Person: Lukasz Biernat
Address: 60 Commercial St # 401, Concord, New Hampshire 03301
Phone Number: (603) 228-7555
Website Address: concordhospital.org
Annual Revenue (USD): $500.000 to $999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Biernat Lukasz MD was started in 2010 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Lukasz Biernat for inquiries that concern Biernat Lukasz MD by calling the company number (603) 228-7555, as your correspondence is most welcome. Additionally, the physical location of the single location of Biernat Lukasz MD can be found at the coordinates 43.21936,-71.53638 as well as the street address 60 Commercial St # 401 in Concord, New Hampshire 03301.

For its online presence, you may visit Biernat Lukasz MD’s website at concordhospital.org and engage with its social media outlets through on Twitter and on Facebook.